Amphastar Pharmaceuticals AMPH Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's total current assets?
- Amphastar Pharmaceuticals (AMPH) reported total current assets of $633.68M in Q1 2026.
- How has Amphastar Pharmaceuticals's total current assets changed year-over-year?
- Amphastar Pharmaceuticals's total current assets increased by 7.8% year-over-year, from $587.96M to $633.68M.
- What is the long-term trend for Amphastar Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's total current assets has grown at a 17.9% compound annual growth rate (CAGR), from $279.68M to $636.02M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.